Therefore, this study has not only established a role of the HSP40-CMA axis in maintaining mitotic integrity, but also identified DNAJA2 and the CMA pathway factors as potential targets to enhance cancer immunotherapy, providing strategies to advance HSPs-based cancer therapy. The gene discussed is DNAJB1; the disease is cancer.